Literature DB >> 24464042

Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation.

Xuelai Fan1, Wu Yang Jin1, Jie Lu2, Jin Wang3, Yu Tian Wang4.   

Abstract

Rapid and reversible methods for altering the levels of endogenous proteins are critically important for studying biological systems and developing therapeutics. Here we describe a membrane-permeant targeting peptide-based method that rapidly and reversibly knocks down endogenous proteins through chaperone-mediated autophagy in vitro and in vivo. We demonstrate the specificity, efficacy and generalizability of the method by showing efficient knockdown of various proteins, including death associated protein kinase 1 (160 kDa), scaffolding protein PSD-95 (95 kDa) and α-synuclein (18 kDa), with their respective targeting peptides in a dose-, time- and lysosomal activity-dependent manner in rat neuronal cultures. Moreover, we show that, when given systemically, the peptide system efficiently knocked down the targeted protein in the brains of intact rats. Our study provides a robust and convenient research tool for manipulating endogenous protein levels and may also lead to the development of protein knockdown-based therapeutics for treating human diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24464042      PMCID: PMC3937121          DOI: 10.1038/nn.3637

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  49 in total

1.  A peptide carrier for the delivery of biologically active proteins into mammalian cells.

Authors:  M C Morris; J Depollier; J Mery; F Heitz; G Divita
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

2.  Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions.

Authors:  Michelle Aarts; Yitao Liu; Lidong Liu; Shintaro Besshoh; Mark Arundine; James W Gurd; Yu-Tian Wang; Michael W Salter; Michael Tymianski
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

3.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.

Authors:  Ana Maria Cuervo; Leonidas Stefanis; Ross Fredenburg; Peter T Lansbury; David Sulzer
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

4.  Intracellular protein degradation in serum-deprived human fibroblasts.

Authors:  L A Slot; A M Lauridsen; K B Hendil
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

5.  Ammonia inhibition of protein degradation in isolated rat hepatocytes. Quantitative ultrastructural alterations in the lysosomal system.

Authors:  P O Seglen; A Reith
Journal:  Exp Cell Res       Date:  1976-07       Impact factor: 3.905

6.  Regulation of catabolism of microinjected ribonuclease A requires the amino-terminal 20 amino acids.

Authors:  J M Backer; L Bourret; J F Dice
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

7.  alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype glutamate receptor (AMPAR) endocytosis is essential for N-methyl-D-aspartate-induced neuronal apoptosis.

Authors:  Yushan Wang; William Ju; Lidong Liu; Sami Fam; Sandra D'Souza; Changiz Taghibiglou; Michael Salter; Yu Tian Wang
Journal:  J Biol Chem       Date:  2004-08-19       Impact factor: 5.157

8.  Expression of death-associated protein kinase and recruitment to the tumor necrosis factor signaling pathway following brief seizures.

Authors:  David C Henshall; Tomohiro Araki; Clara K Schindler; Sachiko Shinoda; Jing-Quan Lan; Roger P Simon
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

9.  Degradation of proteins microinjected into IMR-90 human diploid fibroblasts.

Authors:  N T Neff; L Bourret; P Miao; J F Dice
Journal:  J Cell Biol       Date:  1981-10       Impact factor: 10.539

10.  Contextual specificity in peptide-mediated protein interactions.

Authors:  Amelie Stein; Patrick Aloy
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more
  45 in total

1.  Estrogen Modulates ubc9 Expression and Synaptic Redistribution in the Brain of APP/PS1 Mice and Cortical Neurons.

Authors:  Yu-Jie Lai; Lu Liu; Xiao-Tong Hu; Ling He; Guo-Jun Chen
Journal:  J Mol Neurosci       Date:  2017-02-01       Impact factor: 3.444

Review 2.  Targeted Protein Degradation by Small Molecules.

Authors:  Daniel P Bondeson; Craig M Crews
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-10-12       Impact factor: 13.820

3.  Knocking down Goliath.

Authors:  Erika Pastrana
Journal:  Nat Methods       Date:  2014-03       Impact factor: 28.547

4.  An E3-ligase-based method for ablating inhibitory synapses.

Authors:  Garrett G Gross; Christoph Straub; Jimena Perez-Sanchez; William P Dempsey; Jason A Junge; Richard W Roberts; Le A Trinh; Scott E Fraser; Yves De Koninck; Paul De Koninck; Bernardo L Sabatini; Don B Arnold
Journal:  Nat Methods       Date:  2016-06-06       Impact factor: 28.547

Review 5.  Emerging modes-of-action in drug discovery.

Authors:  Eric Valeur; Frank Narjes; Christian Ottmann; Alleyn T Plowright
Journal:  Medchemcomm       Date:  2019-06-25       Impact factor: 3.597

6.  A novel pathway regulates social hierarchy via lncRNA AtLAS and postsynaptic synapsin IIb.

Authors:  Mei Ma; Wan Xiong; Fan Hu; Man-Fei Deng; Xian Huang; Jian-Guo Chen; Heng-Ye Man; Youming Lu; Dan Liu; Ling-Qiang Zhu
Journal:  Cell Res       Date:  2020-01-20       Impact factor: 25.617

Review 7.  Chemical biology strategies for posttranslational control of protein function.

Authors:  Rishi Rakhit; Raul Navarro; Thomas J Wandless
Journal:  Chem Biol       Date:  2014-09-18

8.  Using injectoporation to deliver genes to mechanosensory hair cells.

Authors:  Wei Xiong; Thomas Wagner; Linxuan Yan; Nicolas Grillet; Ulrich Müller
Journal:  Nat Protoc       Date:  2014-09-18       Impact factor: 13.491

Review 9.  Defective autophagy in Parkinson's disease: lessons from genetics.

Authors:  H Zhang; C Duan; H Yang
Journal:  Mol Neurobiol       Date:  2014-07-04       Impact factor: 5.590

Review 10.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.